Skip to main content

Table 4 The formula of established prediction methods for significant fibrosis, advanced fibrosis and cirrhosis

From: Cytokeratin 18 can help predict liver fibrosis in HCV infected patients with type 2 diabetes mellitus

  Significant fibrosis (F0-1 vs F2-4) Advanced fibrosis (F0-2 vs F3-4) Cirrhosis (F0-3 vs F4)
TE + CK18 0.945*TE + 1.252*CK18 − 6.765 1.003*TE + 0.335*CK18 − 9.157 0.465*TE + 0.576*CK18 − 6.903
APRI + CK18 0.399*APRI + 1.858*CK18 − 0.680 − 0.022*APRI + 1.164*CK18 − 0.987 − 0.006*APRI + 1.175*CK18 − 2.137
FIB-4 + CK18 0.331*FIB-4 + 1.823*CK18 − 0.894 0.227*FIB-4 + 1.133*CK18 − 1.452 0.442*FIB-4 + 1.226*CK18 − 3.228
  1. Numbers in parentheses are the 95% confidence interval
  2. AUROC, area under the receiver operating characteristic; APRI, aspartate transaminase-to-platelet ratio; CK18, cytokeratin 18; FIB-4, fibrosis-4 index; TE, transient elastography